Mineralocorticoid Receptors, Salt-Sensitive Hypertension, and Metabolic SyndromeFUJITA, Toshiro.Hypertension (Dallas, Tex. 1979). 2010, Vol 55, Num 4, pp 813-818, issn 0194-911X, 6 p.Article

Insulin resistance and salt-sensitive hypertension in metabolic syndromeFUJITA, Toshiro.Nephrology, dialysis, transplantation (Print). 2007, Vol 22, Num 11, pp 3102-3107, issn 0931-0509, 6 p.Article

High-risk patients and multifactorial treatmentFUJITA, Toshiro; MANCIA, Giuseppe.The American journal of cardiology. 2007, Vol 100, Num 3, issn 0002-9149, 63 p., SUPAConference Proceedings

Stroke prevention in patients with atrial fibrillationONO, Ayumu; FUJITA, Toshiro.Journal of clinical neuroscience. 2003, Vol 10, Num 1, pp 71-73, issn 0967-5868, 3 p.Article

Olmesartan: a new A II antagonist in cardiovascular risk prevention: A satellite symposium to the Eleventh European Meeting on Hypertension, 17 June 2001FUJITA, Toshiro; BRUNNER, Hans.Journal of human hypertension. 2002, Vol 16, issn 0950-9240, 30 p., SUP2Conference Proceedings

A numerical model of acid-base transport in rat distal tubuleHANGIL CHANG; FUJITA, Toshiro.American journal of physiology. Renal physiology. 2001, Vol 50, Num 2, pp F222-F243, issn 1931-857XArticle

Angiotensin converting enzyme protects acetylcholine-induced relaxation from its attenuation by formyl-methionyl-leucyl-phenylalanine in rat aortaANDO, Katsuyuki; FUJITA, Toshiro.Journal of hypertension. 2001, Vol 19, Num 2, pp 223-228, issn 0263-6352Article

Renin-angiotesin system and hypertensionFUJITA, Toshiro.Internal medicine (Tokyo. 1992). 2001, Vol 40, Num 2, pp 156-158, issn 0918-2918Conference Paper

Erythrophagocytosis by renal tubular cellsMIMURA, Imari; TOJO, Akihiro; UOZAKI, Hiroshi et al.Kidney international. 2008, Vol 74, Num 3, pp 398-398, issn 0085-2538, 1 p.Article

Adrenomedullin protects against oxidative stress-induced podocyte injury as an endogenous antioxidantOBA, Shigeyoshi; HINO, Masayo; FUJITA, Toshiro et al.Nephrology, dialysis, transplantation (Print). 2008, Vol 23, Num 2, pp 510-517, issn 0931-0509, 8 p.Article

Hypoxia and Hypoxia-Inducible Factor in Renal DiseaseNANGAKU, Masaomi; INAGI, Reiko; MIYATA, Toshio et al.The Nephron journals. 2008, Vol 110, Num 1, issn 1660-8151, c67-c73Article

New opportunities in cardiovascular patient management : A survey of clinical data on the combination of angiotensin-converting enzyme inhibitors and angiotensin receptor blockersWEBER, Michael A.The American journal of cardiology. 2007, Vol 100, Num 3, issn 0002-9149, 45J-52J, SUPAConference Paper

A new dawn in cardiovascular protection II: The challenge of end-organ protection in high-risk patientsZANCHETTI, Alberto; FUJITA, Toshiro; MANCIA, Giuseppe et al.Journal of hypertension. 2005, Vol 23, issn 0263-6352, 51 p., SUP1Conference Proceedings

Comparative antihypertensive efficacy of olmesartan: comparison with other angiotensin II receptor antagonistsOPARIL, S.Journal of human hypertension. 2002, Vol 16, pp S17-S23, issn 0950-9240, SUP2Conference Paper

Blood pressure lowering only or more? Has the jury reached its verdict?JULIUS, Stevo.The American journal of cardiology. 2007, Vol 100, Num 3, issn 0002-9149, 32J-37J, SUPAConference Paper

Role of Cys-603 in dimer/oligomer formation of the breast cancer resistance protein BCRP/ABCG2KAGE, Kumie; FUJITA, Toshiro; SUGIMOTO, Yoshikazu et al.Cancer science. 2005, Vol 96, Num 12, pp 866-872, issn 1347-9032, 7 p.Article

Relevance of blood pressure variation in the circadian onset of cardiovascular eventsGILES, Thomas.Journal of hypertension. 2005, Vol 23, pp S35-S39, issn 0263-6352, SUP1Conference Paper

Angiotensin II as a cardiovascular risk factorGAVRAS, I; GAVRAS, H.Journal of human hypertension. 2002, Vol 16, pp S2-S6, issn 0950-9240, SUP2Conference Paper

Anti-atherosclerotic efficacy of olmesartanMIYAZAKI, M; TAKAI, S.Journal of human hypertension. 2002, Vol 16, pp S7-S12, issn 0950-9240, SUP2Conference Paper

Endoscopic treatment of obstructed peritoneal catheterTAKARA, Yohei; ISHIBASHI, Yoshitaka; FUJISHIRO, Mitsuhiro et al.Kidney international. 2011, Vol 80, Num 6, issn 0085-2538, p. 679Article

Podocyte Injury Induced by Albumin Overload in vivo and in vitro : Involvement of TGF-Beta and p38 MAPKYOSHIDA, Shigetaka; NAGASE, Miki; SHIBATA, Shigeru et al.The Nephron journals. 2008, Vol 108, Num 3, issn 1660-8151, e57-e68Article

Fluvastatin ameliorates podocyte injury in proteinuric rats via modulation of excessive rho signalingSHIBATA, Shigeru; NAGASE, Miki; FUJITA, Toshiro et al.Journal of the American Society of Nephrology. 2006, Vol 17, Num 3, pp 754-764, issn 1046-6673, 11 p.Article

Magnesium inhibits norepinephrine release by blocking N-type calcium channels at peripheral sympathetic nerve endingsSHIMOSAWA, Tatsuo; TAKANO, Koji; ANDO, Katsuyuki et al.Hypertension (Dallas, Tex. 1979). 2004, Vol 44, Num 6, pp 897-902, issn 0194-911X, 6 p.Article

The new oral angiotensin II antagonist olmesartan medoxomil: a concise overviewBRUNNER, H. R.Journal of human hypertension. 2002, Vol 16, pp S13-S16, issn 0950-9240, SUP2Conference Paper

Evaluation of a new automated chemiluminescence immunoassay for FGF23SHIMIZU, Yuichiro; FUKUMOTO, Seiji; FUJITA, Toshiro et al.Journal of bone and mineral metabolism (English ed.). 2012, Vol 30, Num 2, pp 217-221, issn 0914-8779, 5 p.Article